Although a new community healthcare monitoring report notes some improvement in filling vacancies at Gauteng clinics, concerns remain over staff shortages and the impact this has on providing quality care, especially to people living with HIV. Thabo Molelekwa reports.
Pharmaceutical companies Merck and Pfizer recently announced early results from clinical trials showing that two new antiviral medicines are highly effective in reducing COVID-19 deaths and hospitalisation. The Medicines Patent Pool then announced licensing deals with both companies that will allow for generic versions of the two drugs to be produced. Catherine Tomlinson unpacks the licenses and asks whether generic versions of these pills might now be made in Africa.
A UNAIDS report published earlier this year estimates that just under 4.5 million men and boys accessed voluntary male medical circumcision (VMMC) services in South Africa by the end of 2019 with 47% of these having been performed from 2016 to 2019. Thabo Molelekwa reports on the impact COVID-19 has had on VMMCs and the challenges related to resuming this service in the country.
In 2014, South Africa launched an HPV vaccination campaign targeting 9-year-old public school learners in Grade 4. It involves delivering two doses of vaccine six months apart. Laura Owings asks how the campaign is going and what recent real-world HPV vaccine effectiveness data from the United Kingdom might mean for South Africa.
Findings from a study conducted in Mqanduli in the Eastern Cape show the prevalence of stunting among children younger than five for that area was 24%. Luvuyo Mehlwana unpacks the findings and the plans the provincial health department has in place to address the risk factors driving stunting among children in the Eastern Cape.
Budgets alone do not solve structural issues, but what it does is provide some insight into the government’s plans for addressing its broader developmental priorities. Russel Rensburg unpacks what the medium-term budget policy statement means for the health sector.
According to new estimates from the World Health Organization around 61 000 people died of TB in South Africa in 2020, an increase of around 5% over 2019. That works out to over 1 100 TB deaths in the country every week. We urgently need a transparent TB recovery plan and we need both President Cyril Ramaphosa and Health Minister Joe Phaahla to invest real political capital in the implementation of the plan, the authors argue.
A 36-year-old mother living with HIV from Thabong in Welkom in the Free State is among the many millions of people in South Africa who rely on public healthcare services. Also, like many others, the COVID-19 pandemic and its associated disruptions have left her in a constant struggle with anxiety. Refilwe Mochoari asks what mental health services are available to people in the Free State who depend on the public healthcare system.
Though the numbers are relatively uncertain, it is estimated that between four and five million people in South Africa are living with diabetes. One reason for the uncertainty is a lack of testing. A lack of testing also means that many people get diagnosed too late in the course of the disease. Elri Voigt asks what we do and do not know about diabetes in the country and what should be done about it.
Working with Groote Schuur Hospital’s frontline COVID team, Psychiatry Professor Jackie Hoare help manage the mental health of patients admitted with severe COVID pneumonia and also the mental health needs of fellow healthcare workers. Bienne Huisman caught up with her to talk about providing counselling at the bedside of COVID patients and how we deal with the complexities of grief in a time of COVID-19.
The different types of COVID-19 tests are far from equal. Picking a test is generally a matter of speed versus accuracy and, most importantly, why you need a test and when. What are the limitations of these tests? Is there any quality control? What are the chances of false positives and false negatives? Elsabé Brits surveys the landscape of tests available in South Africa and asks which type is most appropriate in what situation.
Initially hamstrung by low and uncertain supplies of COVID-19 vaccines, government is arguably now in a better position to campaign actively to accelerate vaccine demand, albeit in the midst of an often-harmful viral “infodemic”. Chris Bateman asks what can be done to boost demand for the jab.
